mcc-555 has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, G; Lin, M; Lu, G; Sun, N; Wu, Y | 1 |
| Foster, JR; Pickavance, LC; Widdowson, PS; Wilding, JP; Williams, G | 1 |
| Ishii, S; King, P; Pickavance, L; Tanaka, H; Widdowson, PS; Williams, G | 1 |
3 other study(ies) available for mcc-555 and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
High-throughput quantification of a novel thiazolidinedione MCC-555 in rat plasma by ultra-fast liquid chromatography and its application in pharmacokinetic studies.
Topics: Animals; Chromatography, Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Pharmacokinetics; Rats; Thiazolidinediones | 2009 |
Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.
Topics: Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Administration Schedule; Insulin; Islets of Langerhans; Male; Nitric Oxide Synthase; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones | 2003 |
The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
Topics: Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Drinking; Glucose; Glucose Intolerance; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Time Factors | 1998 |